Omada Health, Inc. (NASDAQ:OMDA) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Analysts rate Omada Health a "Moderate Buy" — 13 firms cover the stock (10 buy, 2 hold, 1 sell) with an average 12‑month target of $21.64 versus Monday's open of $14.33, implying meaningful upside.
• Recent quarter beat expectations: Omada reported $0.08 EPS versus a consensus of ($0.04) and $75.85M in revenue, though the company still shows a negative P/E (-84.29) and analysts expect a FY EPS of about -$0.04.
• Mixed insider and institutional activity: CEO and CFO have trimmed positions (insiders sold ~8,776 shares worth $120K in 90 days), while large institutions including Cigna and others have initiated or increased sizable stakes (Cigna's stake cited at roughly $76.2M).

Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the thirteen ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and ten have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $21.6364.

Several equities research analysts recently issued reports on OMDA shares. Barclays dropped their target price on shares of Omada Health from $22.00 to $17.00 and set an "overweight" rating on the stock in a report on Tuesday, March 3rd. Wells Fargo & Company began coverage on shares of Omada Health in a research note on Thursday, January 8th. They set an "equal weight" rating and a $17.00 price target on the stock. Citizens Jmp began coverage on shares of Omada Health in a research note on Tuesday, April 14th. They set an "outperform" rating and a $18.00 price target on the stock. Canaccord Genuity Group dropped their price target on shares of Omada Health from $28.00 to $22.00 and set a "buy" rating on the stock in a research note on Friday, March 6th. Finally, Morgan Stanley dropped their price target on shares of Omada Health from $32.00 to $30.00 and set an "overweight" rating on the stock in a research note on Friday, March 6th.

Omada Health Stock Performance

Shares of OMDA stock opened at $14.33 on Monday. Omada Health has a 12-month low of $10.28 and a 12-month high of $28.40. The firm's 50 day moving average is $13.04 and its 200 day moving average is $16.32. The stock has a market capitalization of $844.32 million and a P/E ratio of -84.29.

Omada Health (NASDAQ:OMDA - Get Free Report) last issued its earnings results on Thursday, March 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.12. The company had revenue of $75.85 million during the quarter. As a group, equities analysts predict that Omada Health will post -0.04 earnings per share for the current year.

Insider Transactions at Omada Health

In other news, CEO Sean P. Duffy sold 4,063 shares of Omada Health stock in a transaction on Monday, March 9th. The shares were sold at an average price of $14.34, for a total transaction of $58,263.42. Following the transaction, the chief executive officer owned 117,598 shares in the company, valued at $1,686,355.32. This trade represents a 3.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Steven L. Cook sold 1,884 shares of Omada Health stock in a transaction on Friday, March 13th. The stock was sold at an average price of $13.94, for a total transaction of $26,262.96. Following the transaction, the chief financial officer owned 200,512 shares in the company, valued at $2,795,137.28. This represents a 0.93% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 8,776 shares of company stock worth $120,483 in the last 90 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Cigna Investments Inc. New bought a new stake in shares of Omada Health during the 3rd quarter valued at $76,161,000. BIT Capital GmbH bought a new stake in shares of Omada Health during the 3rd quarter valued at $13,639,000. Divisadero Street Capital Management LP bought a new stake in shares of Omada Health during the 3rd quarter valued at $30,510,000. Tudor Investment Corp ET AL bought a new stake in shares of Omada Health during the 3rd quarter valued at $987,000. Finally, Fortress Investment Group LLC raised its position in shares of Omada Health by 43.1% during the 3rd quarter. Fortress Investment Group LLC now owns 225,000 shares of the company's stock valued at $4,975,000 after purchasing an additional 67,750 shares during the period.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.